TI
COLL icon

Tidal Investments’s Collegium Pharmaceutical COLL Stock Holding History

Tidal Investments’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$287K Buy
+8,687
New +$368K ﹤0.01% 2059
2025
Q4 		– Sell
-5,790
Closed -$203K – 2172
2025
Q3 		$203K Buy
+5,790
New +$201K ﹤0.01% 1936

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Tidal Investments's COLL Position: Q1 2026 in Review

Tidal Investments opened a new position in Collegium Pharmaceutical (COLL) in Q1 2026: 8,687 shares worth $287K. The stake represents ﹤0.01% of the portfolio and ranks #2059 among its holdings. This is a return to the name: Tidal Investments previously reported a position in COLL as recently as Q3 2025.

Tidal Investments first reported a position in COLL in Q3 2025 and has held it in 2 quarters since. 266 funds tracked by Wall St. Rank hold COLL as of Q1 2026.

  • Tidal Investments held 8,687 shares of Collegium Pharmaceutical worth $287K as of Q1 2026.
  • Collegium Pharmaceutical was a new Tidal Investments position in Q1 2026.
  • Collegium Pharmaceutical made up ﹤0.01% of Tidal Investments's portfolio in Q1 2026, its #2059 holding.
  • Tidal Investments first reported a position in Collegium Pharmaceutical in Q3 2025 and has held it in 2 quarters since.
  • 266 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2026.

Based on Tidal Investments's 13F filing for Q1 2026, filed 15 May 2026.